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Effects of dietary protein content in streptozotocin-diabetic rats. We
evaluated the influence of increased dietary protein intake on glomer-
ular structure and function in Lewis rats made diabetic with streptozo-
tocin. We found that diabetic animals on a 20% or 50% protein diet ate
approximately 50% more protein and excreted about 50% more urinary
urea nitrogen than did their respective similarly-fed nondiabetic con-
trols. The 50% protein diet was associated with higher glomerular
filtration rates (GFR) and renal blood flows (RBF) at two months in both
diabetic and control animals compared to their respective controls on
the lower protein diet. However, GFR and RBF were not significantly
higher in the diabetic animals on the 50% protein diet than in the
controls on the 20% diet and were slightly, albeit not significantly lower
than controls on the 50% diet. Glomerular capillary pressure (PGC)
tended to be lower in the diabetic compared to their respective controls,
while the high protein diet was associated with higher PGC in diabetic
and nondiabetic animals. The PGC in the 50% diabetic rats was not
different from the PGC in the nondiabetic rats. Urinary albumin
excretion (UAE) rate was greater in the diabetic than in the nondiabetic
animals. UAE was greatest in the high protein diabetic animals at six
months. Glomerular basement membrane thickness after six months of
diabetes was increased essentially equally in both normal and high-
protein fed diabetic groups and was largely uninfluenced by diet in the
controls. Fractional mesangial volume was increased and relative
filtration surface was decreased only in the 50%-protein diet diabetic
rats at six months. Thus, high protein diet was associated with
increased fractional mesangial volume in diabetic rats, but this could
not be explained by increased glomerular capillary flows or pressures.
The mechanism of acceleration of mesangial expansion by high protein
diet in diabetic animals was not elucidated by these studies.
Clinical diabetic nephropathy develops in 25 to 45% of
patients with insulin-dependent diabetes [1—31 as a consequence
of advanced lesions of diabetic glomerulopathy [4, 5]. Almost
all patients with type I diabetes develop glomerular basement
membrane (GBM) thickening [4], However, it is severe diffuse
mesangial expansion rather than GBM thickening which is
closely associated with overt diabetic nephropathy [4]. Once
nephropathy becomes manifest through proteinuria and hyper-
tension, the disease progresses through declining glomerular
filtration rate (GFR) towards terminal renal failure [6], and the
level of reduction of GFR in these patients is closely related to
the decrease in available glomerular peripheral capillary filtra-
tion surface area [7]. Multiple regression analyses have shown
that this ifitration surface is remarkably closely correlated with
glomerular volume and mesangial volume per glomerulus, to-
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gether [7]. Thus, a moderate degree of mesangial expansion
within a relatively small glomerulus is associated with much
greater restriction of filtration surface than a similar degree of
mesangial expansion occurring in a relatively large glomerulus
[7]. From these studies it can be understood that an increase in
the volume fraction of the mesangium (fraction of the cross-
sectional area of the glomerular tuft occupied by mesangium)
affects GFR by distorting the geometry of contiguous glomeru-
lar capillaries and that the impact of mesangial expansion on
capillary filtration surface is influenced by the volume of the
glomerulus in which the change is occurring [7].
We have previously shown that rats with severe (insulin
untreated), long standing, experimentally-induced diabetes mel-
litus develop increased mesangial volume fraction [8—101 and
that this is associated with a reduction in relative filtration
surface [8]. In addition, we have in the past suggested that
experimental manipulations which have been shown by others
to influence intraglomerular hemodynamics can influence the
rate at which these mesangial lesions develop [11, 12]. Thus, we
reported that uninephrectomy, usually associated with a rela-
tive increase in GFR per nephron in the remaining kidney [13,
14], was associated with an acceleration in mesangial volume
expansion in severely diabetic rats [11]. However, on further
analysis we determined that the increase in mesangial volume
which resulted from uninephrectomy in diabetic rats was due to
glomerular enlargement and that uninephrectomy did not in-
crease mesangial volume fraction [10]. We have also shown,
albeit only by semiquantitative light microscopy, that Goldblatt
hypertension in severely diabetic rats produces acceleration of
mesangial lesions in the "unclipped" kidney while the
"clipped" kidney was somewhat protected from these changes
[12]. Importantly, mesangial expansion did not occur in the
"unclipped" kidney of nondiabetic Goldblatt hypertensive rats.
This kidney also being exposed to hemodynamic stress. The
unclipped kidneys of both diabetic and nondiabetic hyperten-
sive rats developed lesions of focal and segmental glomerular
sclerosis (FSGS). However, the percent of glomeruli with
FSGS was not different comparing the diabetic and control
unclipped kidneys [121.
More recently it has been shown that Munich-Wistar rats
with experimental diabetes modulated with daily insulin treat-
ment have increased single nephron glomerular filtration rate
(SNGFR) due to increased glomerular blood flow, glomerular
capillary pressure, and transcapillary hydraulic pressure [15].
However, more severely hyperglycemic, insulin untreated rats
similar to the model we described above [8— 12] did not have
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these physiologic changes [15]. It has also been shown that a
high protein diet aggravated the hemodynamic changes of
insulin-treated diabetic Munich-Wistar rats, while a low protein
diet largely prevented these alterations [16]. Further, the high
protein diet in these rats was associated with greater incidence
of FSGS lesions and increased levels of proteinuria while the
low protein diet was associated with protection from these
abnormalities [16]. However, as calculated from their data [17]
these investigators were unable to demonstrate increased
mesangial volume fraction in the diabetic rats on either the high
or low protein diets. Since our studies in man support a central
role for such mesangial expansion in the genesis of overt
diabetic nephropathy [4, 7], we chose to use expansion of the
volume fraction of the mesangium as the critical endpoint in
these current studies of the influence of a high protein diet on
severely hyperglycemic rats. We found that a high protein diet
in severely diabetic rats was associated with an increased rate
of fractional mesangial expansion but was not associated with
glomerular hemodynamic abnormalities.
Methods
Induction of diabetes
Age matched animals were randomly assigned to the diabetic
and control groups in a staggered time design so that the
appropriate number of animals would emerge for study each
day within a few days of the time designations. Diabetes was
induced in male Lewis rats [8] approximately 50 days of age
(150 g) at the start of the experiment by the intravenous
injection of 55 mg/kg body weight of streptozotocin (Upjohn
Company, Kalamazoo, Michigan, USA). Diabetes was con-
firmed by the development of severe non-fasting hyperglycemia
with blood glucose levels in excess of 400 mg/dl by one week
after streptozotocin administration. Animals with less severe
diabetes were not studied further.
Dietary manipulations
Diabetic and nondiabetic animals were further randomly
divided into two groups; one group received a 20%protein diet
and the other a 50% protein diet. The compositions of these
diets (Teklad Company, Madison, Wisconsin, USA) are pre-
sented in Table 1. Sufficient animals were prepared so that
studies could be performed at two and at six months after the
induction of diabetes. Thus, a total of eight groups were
available and their description and designation by abbreviation
are presented in Table 2.
Food intake was measured at two and four months after
induction of diabetes by placing rats in cages with a weighed
amount of food for two days. The food consumption on the
second day was measured and expressed as kcal per rat per
day. In addition, 24-hour urine urea nitrogen excretion was
measured at six months in rats from each of the four groups
using a Beckman Analyzer (Beckman Instruments, Fullerton,
California, USA).
Renal histology
Rena/fixation. Left kidneys were perfused under physiologic
pressures with 0.17 M sodium cacodylate buffer for at least 60
seconds, followed by perfusion with 1% glutaraldehyde in
cacodylate buffer for at least 60 seconds longer. Virtually total
Table 1. Dietary constituents
20% Protein 50% Protein
3.5 K cal/g 3.5 K cal/g
5% fat 5% fat
1.1% calcium 1.1% calcium
0.8% phosphorous 0.8% phosphorous
23.0% caseina 57.5% caseina
61.1% cornstarch 27.3% cornstarch
4.8% corn oil 4.4% corn oil
5.0% cellulose 5.0% cellulose
added vitamins added vitamins
and minerals" and minerals"
including 0.1% including 0.1%
sodium and sodium and
0.36% potassium 0.36% potassium
a Casein added to diet was 87% protein, 1% milkfat, 2% ash and 10%
moisture.
b Background sodium in the 20% protein diet = 250 ppm and in the
50% protein diet = 200 ppm. Background potassium in both diets = 65
to 75 ppm.
Table 2. Groups defined
Group Abbreviation
1. Diabetic, 20% protein, 2 mo D-20-2
2. Control, 20% protein, 2 mo C-20-2
3. Diabetic, 20% protein, 6 mo D-20-6
4. Control, 20% protein, 6 mo C-20-6
5. Diabetic, 50% protein, 2 mo D-50-2
6. Control, 50% protein, 2 mo C-50-2
7. Diabetic, 50% protein, 6 mo D-50-6
8. Control, 50% protein, 6 mo D-50-6
renal blanching was required for the kidney to be accepted for
further study. The unfixed kidney was used to determine renal
weight. Each perfusion fixed kidney was then excised from the
animal and bisected. Small pieces (1 mm3) were cut from the
cortex of one of the kidney halves, stored in 1% glutaraldehyde
overnight and processed for electron microscopy. The other
half of each kidney was placed in glutaraldehyde overnight and
processed for light microscopy.
Light microscopy (LM). Tissues rinsed three times in cacody-
late buffer (at least 24 hours per rinse) were embedded in
paraffin. Four micron sections of the halved kidneys were
stained with PAS and were studied without knowledge of the
group designation to determine the average glomerular volume
by point counting as previously described [18]. In addition,
kidneys from 10 animals per group from the animals sacrificed
at six months were evaluated in order to estimate the frequency
of the lesions of focal segmental glomerular sclerosis (FSGS). A
minimum of 100 glomeruli were evaluated from each animal.
The glomeruli studied were chosen by unbiased sampling in
which fields were chosen at low power and glomeruli in those
fields examined for FSGS at high power, making sure that
glomeruli from both superficial and deep zones of cortex were
examined and that glomeruli were not examined twice.
Electron microscopy (EM). Tissues rinsed as above were
post-fixed in 1% osmium tetroxide, dehydrated in graded alco-
hol and embedded in PolyBed 812 (Polysciences, Warrington,
Pennsylvania, USA) [8]. One micron sections were cut from
three blocks of tissue per animal and stained with toluidine
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blue. The centermost glomerulus at least one tubular diameter
from the section edge was selected for EM [4, 8]. Ultrathin
sections were stained with uranyl acetate and lead citrate and
examined with a JEOL 100CX electron microscope (JEOL
USA, Peabody, Massachusetts, USA). Unbiased photomicro-
graphs were obtained systematically as previously described [4,
8]. Micrographs were printed at a final magnification of approx-
imately x22,000. A calibration grid (1134 lines/mm) was photo-
graphed with each set of micrographs to monitor the exact
magnification.
Coded EM photomicrographs were studied. The average
width of the GBM was determined using the orthogonal inter-
cept method [19]. In brief, a grid with six, evenly spaced
intersecting lines (three horizontal and three vertical) is placed
over each photomicrograph and GBM measurements are made
at each point that a line on the grid intercepts an endothelial-
GBM interface. The width is measured on a line orthogonal to
the edge of the GBM at the endothelial side of the intercept.
Fractional volumes of glomerular components were measured
by placement of the grid having nine coarse points and an
additional eight fine points over each electron micrograph to
determine the proportion (or fractional volume) of points falling
on the cellular or matrix components of the glomerulus [4, 81.
The transition between the peripheral capillary area and the
mesangium was determined on the basis of widening of the
distance and disappearance of the parallelism between the
endothelial and epithelial cells [4, 81. This demarcation was
used to identify the beginning of the mesangium as well as the
end of the peripheral capillary wall (that is, the endothelial
cell-GBM-epithelial cell interface). The fractional volumes of
the total mesangium and its matrix and cellular components
were measured, excluding the glomerular basement membrane
lying between the epithelial cell and the mesangium.
Relative surface densities (Sv) of the peripheral capillary wall
and of the endothelial-mesangial interface were measured with
the grid by standard stereologic techniques. Sv represents twice
the number of times the lines on the grid intersected the surface
being studied divided by the total length of the lines [4, 8].
Mesangial volume and peripheral capillary filtration surface
measures were also expressed as absolute values per glomeru-
lus, this based upon multiplication of the relative density values
by the glomerular volume [4, 8, 20].
Urinary albumin excretion (UAE). UAE was determined by
radial immunodiffusion as previously described by placing
animals in metabolic cages for 18 hours (3 p.m. to 9 a.m,) with
free access to water but with no food [21]. Values for 24 hours
were extrapolated from these 18 hour collections [21]. Since the
data were not always normally distributed, they were log
transformed and the log + 2 of the original values are shown.
Renal function studies
In separate experiments animals were studied two months
after being made diabetic as outlined above. Rats were anes-
thetized with mactin (8 to 10 mg/lOO g body wt). Following
tracheostomy placement the femoral artery was canulated and
connected to a Statham P23Db pressure transducer (Statham
Instruments, Los Angeles, California, USA) connected to a
Beckman Dynagraph recorder Model L6N (Beckman Instru-
ments) for estimation of blood pressure [22], and blood was
removed for a baseline hematocrit (Hct); it is these baseline
HCT values which are presented in the Results. At the start of
surgery animals received a bolus of 0.5 mL/100 g body wt of rat
plasma over 20 minutes followed by 0.5 ml of a 1: 1 mixture of
rat plasma and 6.6 tCi H3-inulin (ICN Radiochemicals, Irvine,
California) in Ringer's lactate over 10 minutes followed by a
constant infusion of the same mixture at a rate of 2 ml/hr. The
left kidney was immobilized in a lucite cup in agar as previously
detailed [22]. Following one hour of the constant inulin infu-
sion, the first of three 30-minute clearances was obtained, with
blood for inulin and Hct determinations being removed from the
arterial catheter. A renal vein blood sample for inulin was
drawn at the end of these clearance periods. Renal blood flow
(RBF) was then calculated as follows:
RBF= RPF
1 — Hct
V(U - R)
where renal plasma flow (RPF) = A—R
where V = urine flow rate and U, A and R = inulin concentra-
tions in urine, arterial plasma and renal venous plasma, respec-
tively [23].
The data presented in Results is the GFR from the third of the
three 30-minute clearance periods since renal venous blood was
obtained only at that time, after glomerular capillary pressure
measurements were completed. However, GFR from the sec-
ond and third clearance periods were essentially identical in all
rat groups, indicating stability under the micropuncture condi-
tions described here. There were no significant changes in Hct
in any of the groups of animals studied comparing the baseline
values to those obtained at the end of the first or second
clearance periods. There was a tendency for the Hct values to
be slightly reduced at the end of the third clearance period, but
these reductions were only statistically significant for the D-20
animals (Hct = 51 0.02% pre- vs. 49 0.03% postperiod, P
< 0.003). Proximal tubular pressures were obtained and then
PGC were measured by stopped flow technique as previously
described in detail [13, 22]. Stopped flow pressures were
measured in at least three different nephrons in each animal and
a mean of these pressures calculated. Arterial blood colloid
oncotic pressure (COP) was measured three times in each
animal at half-hour intervals using a temperature controlled
micro-osmometer (1DM, San Diego, California, USA) and a
semipermeable PM-30 Amicori membrane (Amicon Corp., Dan-
vers, Massachusetts, USA) [24, 251. The values were stable
throughout the studies. Thus, only the final values are pre-
sented. PGC was estimated as the sum of the mean stopped-
flow hydrostatic pressure and the mean systemic COP. Efferent
arteriolar pressures were obtained by puncture of "star" ves-
sels as previously reported [22]. Values for afferent (RA) and
efferent (RE) arteriolar resistances were calculated using pub-
lished formulas [261.
Data from animals in these studies were excluded if the
animal's blood pressure (BP) fell below 100 mm Hg during the
final 30 minute clearance period, if the urine output during this
30 minutes was less than 0.4 ml or if the filtration fraction was
less than 0.15.
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Table 3A. Clinical model parameters at 2 months
Blood
glucose
mg/dl
Body
weight
Kidney
weight
KW/BW
Mean
arterial BP
mm Hg
HCT
%
COP
mm HGg
20% 119 337 1.18 0.0035 108 47 13.8
Control SD
N
13
24
30
48
0.09
13
0.0003
13
15
9
2
12
0.5
8
50% X 121 337 1.53 0.0045 113 51 13.3
Control SD
N
5
13
16
48
0.17
13
0.0006
13
11
10
2
12
1.8
7
20% X 541 169 1.36 0.0073 103 50 10.9
Diabetic SD
N
105
36
34
61
0.14
15
0.0013
15
11
8
3
16
1.1
5
50% 509 180 1.73 0.0085 109 52 11.5
Diabetic SD
N
88
39
37
64
0.29
18
O.0017
18
8
13
2
18
1.5
11
ANOVA P value
Diabetes 0.001 0.001 0.001 0.001 NS 0.006 0.001
Diet NS NS 0.001 0.001 NS 0.001 NS
Diabetes x diet NS NS NS NS NS NS NS
Abbreviations are: KW/BW, ratio of kidney weight to body weight; BP, blood pressure; HCT, hematocrit; COP, colloid osmotic pressure.
Validation of indirect glomerular capillary pressures in
diabetic rats
These studies were carried out in five Munich-Wistar rats
made diabetic at 250 10 g body weight (19 weeks of age). Six
age-matched, nondiabetic Munich-Wistar rats served as con-
trols. The diabetic rats were maintained with 0.5 to 2.5 U
insulinlday in order to stabilize plasma glucose levels in the
range of 350 to 450 mg!dl. This strategy was adopted because
increased PGC had been documented by direct measurements
in a similar animal model [15, 16] and because it was important,
for the present studies, to be sure that the indirect measurement
technique would detect increased PGC if such elevations in
pressure could be documented by direct measurements. Both
indirect pressure measurements as described above and direct
pressures measured as previously detailed [13, 27, 28] were
obtained in each of these 11 animals. The indirect PGC in the
diabetic rats was 53.7 2.6 mm Hg (X SD) and was increased
compared to the mean value of 48.4 5.1 mm Hg obtained in
the controls (P <0.01). The direct PGC was also greater in the
diabetic rats (56.2 4.4 mm Hg) as compared to the controls
(48.5 7.3 mm Hg, P < 0.01). There was no significant
difference between direct and indirect pressures comparing
these measurements within either the diabetic or the control
groups. The correlation between the direct and indirect mea-
surements was r = +0.961, P < 0.0001.
Statistics
The primary statistical analytic technique was a three-way or
two-way analysis of variance (ANOVA) using the Control Data
Cyber Computer or the Statworks Package (Cricket Software
Development Co., Philadelphia, Pennsylvania, USA) using the
Apple "Mac Plus" desktop computer (Apple Co., Cupertino,
California). Comparisons between groups were also evaluated
by the Student's t-test or the rank-sum test. Since multiple
comparisons were made, only values of P 0.01 were consid-
ered significant while values of P  0.025 were considered
borderline. All valid data derived from all the animals in these
studies reaching a given time point were included. Thus, the
number of animals used to derive the model parameters (vide
infra) was larger than the number studied in the structural or in
the functional studies, for different animals were used to derive
these latter data.
Results
Clinical model parameters
Body weights of D-20 and D-50 rats were reduced at both two
and six months of diabetes compared to their respective con-
trols (Tables 3A and 3B). However, the diabetic animals grew
steadily, albeit slowly, throughout these studies (Fig. 1), and at
no time appeared emaciated. The diet per se did not influence
body wt at two months (Table 3A) in either the control or the
diabetic groups. However at six months (Table 3B) body wt was
significantly decreased in C-SO as compared to C-20 rats (P <
0.005) and increased in D-50 compared to D-20 animals, albeit
with only borderline statistical significance (P < 0.025).
The blood glucose levels of D-20 and D-5O rats were mark-
edly elevated at two and six months; at two and at six months
of diabetes the blood glucose levels of the D-50 rats was not
significantly different from that of D-20 animals. There was no
difference in glucose levels in C-20-2 compared to C-50-2 rats.
Howevcr, the blood glucose levels of C-2O-6 were higher than
those of C-50-6 rats (P < 0.005). Further, by ANOVA the 50%
protein diet was associated with a highly significant decrease in
blood glucose levels at six months (P = 0.001).
Diabetes resulted in a highly significant reduction in systemic
BP at six months (Table 3B; ANOVA P = 0.001). ANOVA
revealed a very significant effect of increased protein intake and
diabetes in increasing hematocrit values (P = 0.0001). Also,
ANOVA showed that diabetes per se was associated with a
decrease in COP (P = 0.001).
Whole kidney weights were increased by diabetes, high
protein diet, and time (ANOVA P = 0.001 for each). Also,
kidney weight to body weight ratios were increased by high
protein diet and diabetes (Anova P = 0.001 for each) but there
was no significant interaction between these two variables.
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Table 3B. Clinical model parameters at 6 months
Blood
glucose
mg/dl
Body
.
weight
Kidney
.
weight
KW/BW
Mean
arterial BP
mm Hg
HCT
%
COP
mm Hg
Urine urea
nitrogen
mg/24 hrg
20% 138 482 1.25 0.0026 122 49 14.1 112
Control
50%
SD
N
13
20
120
26
22
462
0.10
21
1.58
0.0002
21
0.0034
10
7
123
3
10
53
1.9
7
13.9
31
18
252
Control
20%
SD
N
21
20
621
18
23
244
0.18
22
1.64
0.0003
22
0.0068
10
8
111
2
8
52
0.9
8
12.9
47
19
180
Diabetic
50%
SD
N
113
29
558
38
29
269
0.18
27
2.26
0.0009
27
0.0085
7
10
108
2
12
54
0.4
10
12.4
44
16
356
Diabetic SD
N
88
26
36
29
0.33
27
0.0015
27
8
12
2
15
1.4
12
119
20
ANOVA P value
Diabetes 0.001 0.001 0.001 0.001 0.001 0.001 0.002 0.001
Diet 0.001 0.008 0.001 0.001 NS 0.001 NS 0.001
Diabetes x diet NS NS 0.001 0.022 NS NS NS NS
Abbreviations are: KW/BW, ratio of kidney weight to body weight; BP, blood pressure; HCT, hematocrit; COP, colloid osmotic pressure.
E
0,
'C
0
Time in weeks post-initiation of diabetes and diets
Fig. 1. Body weight throughout the study. Symbols are: (•) C-20; ()
C-SO; (U) D-20; (D) D-50.
Dietary intake
Food consumption expressed as kcal/24 hrs per animal or
kcal/24 hr/l00 g body wt was significantly increased in diabetic
as compared to control rats at two and four months (P < 0.001
for each comparison, Fig. 2). Food intake was greater at four
months in the C-50 compared to the C-20 rats. Otherwise
dietary protein composition did not have a significant influence
on food consumption. Urine urea nitrogen measured at six
months was higher in D-50 than D-20 rats (Table 3B; P < 0.001)
and in C-SO compared to C-20 rats (P < 0.001). Also urine urea
nitrogen was greater in D-20 versus C-20 and D-50 versus C-SO
rats (P < 0.001 for each comparison). The ratios of urinary urea
nitrogen excretion to food consumption showed that the pro-
portionality between protein intake and urine urea nitrogen
output was similar among all groups, this indicating no defect in
intestinal absorption in the diabetic rats. Thus, for example, the
diabetic rats receiving a 20% protein diet ingested approxi-
mately 50% more protein and excreted approximately 50%
more urinary urea nitrogen than nondiabetic animals on the
same diet.
Glomerular morphology
Light microscopy. No lesions of focal segmental or global
glomeruloscierosis were found in any animals from any group at
either two or six months.
Glomerular basement membrane. ANOVA revealed that
both time and diabetes contributed to increasing GBM width
(Table 4). However, diet had no significant effect on this
structural measure either alone or through interactions with the
other variables (Table 4). The width of the GBM of diabetic rats
after two months of diabetes did not differ from that of controls,
whereas at six months GBM width of diabetic rats fed either
20% or 50% protein diets was increased, compared with simi-
larly fed controls. GBM width in D-50-6 rats tended to be
slightly increased compared to D-20-6 animals, but this was of
borderline statistical significance (P < 0.025).
Glomerular volume. Mean glomerular volume increased with
time and the high protein diet (Table 4). While mean glomerular
volumes in D-50-2 and C-50-2 rats were not significantly greater
than those of D-20-2 and C-20-2 rats, respectively, the D-50-6
and C-S0-6 rats had clear glomerular enlargement compared to
the D-20-6 and C-20-6 rats, respectively (P < 0.001 in each
instance).
Mesangium. At two months the volume fraction of the
mesangium (VvMes) did not differ among the four groups of
rats. However, VvMes was markedly increased in D-50-6
animals compared to the C-50-6 (P < 0.001), C-20-6 (P < 0.005),
and D-20-6 rats (P < 0.025, borderline significance). The total
volume of the mesangium was affected individually by diabetes,
diet and time and their interactions (Table 4); these relation-
ships reflected the combined influences of the mean glomerular
volume and the volume fraction of the mesangium. Specifically,
this measure was greater in D-5O-6 animals compared to all
other groups (Table 4). In addition, because of increased
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Fig. 2. Food intake per rat in kca!/24 hr in each of the four groups at two and four months. I = mean SD. Symbols are: () 20% control; (U)
50% control; (PA) 20% diabetic; () 50% diabetic.
Table 4. Renal morphology
2 Months 6 Months
GBM*
width
nm
Glom vol
pin3 x
Total
mes
106
Vv
Mes
Sv
PGBM
TOtal
surface
p.m2 x 106
GBM
width
nm
Glom vol
Total
mes Vv
Mes
Sv
PGBM
Total
surface
p.m2 x 106p.m3 x 106
20% 159 0.96 0.096 0.099 0.151 0.145 193 1.14 0.010 0.089 0.148 0.168
Control SD
IV
7
11
0.15
11
0.042
11
0.033
11
0.017
11
0.031
11
11
12
0.13
12
0.031
12
0.020
12
0.023
12
0.027
12
50% 160 1.04 0.094 0.091 0,154 0.158 186 1.51 0.128 0.085 0.156 0.236
Control SD
N
7
9
0,16
9
0.031
9
0.026
9
0.019
9
0.022
9
12
12
0.16
12
0.030
12
0.018
12
0.014
12
0.039
12
20% 165 0.89 0.080 0.089 0.152 0.136 218 1.18 0.116 0.099 0.141 0.166
Diabetic SD
N
6
8
0.11
8
0.031
8
0.032
8
0.039
8
0.038
8
21
12
0.2
12
0.034
12
0.023
12
0.022
12
0.041
12
50% 166 0.94 0.110 0.115 0.131 0.122 231 1.58 0.219 0.137 0.119 0.137
Diabetic SD
N
5
9
0.15
9
0.047
9
0.041
9
0.031
9
0.033
9
20
12
0.25
12
0.084
12
0.043
12
0.021
12
0.043
12
ANOVA P value
Time 0.001 0.001 0.001 NS 0.02 0.001
Diet NS 0.001 0.001 NS NS 0.003
Diabetes 0.001 NS 0.01 0.003 0.001 0.001
Time x diet NS 0.001 0.02 NS NS 0.003
Time x diabetes 0.001 NS 0.004 NS NS NS
Diet x diabetes NS NS 0.003 0.003 0.006 0.01
Time x diet x NS NS NS NS NS NS
diabetes
Abbreviations are: GBM, glomerular basement membrane; Glom vol, glomerular volume; Total mes, total mesangium; Vv Mes, volume density
of mesangium; Sv PGBM, surface density of peripheral capillary filtration surface.
glomerular volumes in C-50-6 rats, the total mesangium in
C-50-6 rats was greater than in C-20-6 animals (P < 0.01). Both
glomerular volume and volume fraction of the mesangium
contributed to increased total mesangial volume in D-50-6
compared to C-50-6 rats (Table 4).
The measures of surface density of the peripheral filtration
surface were inversely related to those of the volume fraction of
the mesangium. Diabetes and the interaction of diet and diabe-
tes demonstrated the largest influence on this structural param-
eter (Table 4). Thus, at six months this measure was reduced in
D-50 rats compared to all other groups (P < 0.001 vs. C-50-6
and C-20-6; P < 0.025, borderline, vs. D-20-6). Total peripheral
capillary surface was influenced by diabetes, diet and time and
their interactions. It was relatively reduced in D-50-6 animals
and was greatest in control animals on the high protein diet
(Table 4).
Urinary albumin excretion. Diabetes, diet and time (also the
interactions of time and diet and of time and diabetes) all
significantly influenced UAE (all P values by ANOVA <0.01).
After two months of diabetes, UAE did not differ among the
various groups; however, over the next four months the UAE in
D-50-6 rats increased compared to all other groups (Fig. 3).
UAE at six months was also increased in D-20-6 cothpared to
C-20-6 or C-50-6 rats.
Renal physiology. The clinical model parameters in the
animals used for renal physiology studies were generally similar
to the experiments described above, although the blood glucose
levels were somewhat lower and the body weights higher in the
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Fig. 3. Urine albumin excretioh per rat in each of the four groups. The
individual values were log transformed because the values were not
always normally distributed. For ease of plotting, the logs of each of the
original values + 2 are shown. Symbols are: (0) diabetic; (•) non-
diabetic.
respective diabetic groups in the second study (Tables 5 and
3A). In addition, the systemic blood pressure and COP mea-
surements tended to be higher in each of the diabetic and
control groups when compared with the parallel groups in the
first experiment. Nonetheless, virtually all the directions of
differences between the four rat groups for blood glucose, body
weight, kidney weight, BP, HCT (Tables 5 and 3A) and COP
(Tables S and 3B) seen at two months with the first experiments
were present in the second set of studies.
GFR tended to be depressed by diabetes and increased by
high protein intake (ANOVA P = 0.008 and 0.007, respectively,
Table 6). GFR was higher in D-SO than in D-20 rats (P < 0.01)
and in C-SO than C-20 rats (P <0.001). GFR was also greater in
C-SO than D-50 rats (P < 0.01). There was no significant
difference between the GFR of D-50 and C-20 animals.
RBF (not shown) and RPF was decreased by diabetes and
increased by the high protein diet (ANOVA P = 0.001 and
0.007, respectively). RPF was lower in D-50 than C-50 rats and
was not different from C-20 rats. Diabetes was associated with
higher FF (ANOVA P = 0.001, Table 6), presumably largely
because COP was lower in diabetic compared to control ani-
mals (ANOVA P = 0.01).
There were no significant differences in PGC between any of
the groups. However, by ANOVA diabetes was associated with
decreased PGC (ANOVA P = 0.008) while high protein diet
was associated with increased PGC (ANOVA P = 0.001, Table
6). There were no significant differences between any of the
groups in PT. P was higher in D-50 than D-20 animals in this
experiment but was almost identical to that of C-S0-2 and C-20-2
rats. ANOVA revealed a highly significant upward influence of
the high protein diet on this parameter in both diabetics and
controls (P = 0.001). Although diabetes tended to be associated
with lower P, this was only of borderline significance
(ANOVA P = 0.025).
Diabetes tended to be associated with an increase in RA
(ANOVA P = 0.025) while 50% protein diet was associated
with a decrease in this parameter (ANOVA P = 0.001).
Discussion
The studies described here show that expansion in mesangial
volume fraction is accelerated by increased dietary protein
intake in long-term diabetic rats. This effect was not seen for
GBM width. This increase in mesangial volume fraction in the
diabetic rats on the high protein diet occurred despite the
findings that glomerular capillary pressures and flows in these
rats were not different from those of control rats on the normal
diet.
Diabetic animals in both dietary groups developed increased
GBM width compared to controls but the manipulations of
dietary composition, per Se, were not associated with GBM
changes. In contrast, significant increase in the volume fraction
of the mesangium and decrease in filtration surface density
occurred only in the diabetic rats on the 50% protein diet. This
is important since the major clinical manifestations of overt
diabetic nephropathy in humans are related to increased mesan-
gial volume fraction, that is, mesangial expansion which is out
of proportion to glomerular volume [4]. We have shown in type
I diabetes in humans that it is the relationship of absolute
mesangial volume per glomerulus to glomerular volume (or
mesangial volume fraction) which correlates most precisely
with the peripheral glomerular capillary filtration surface [7]
which, in turn, is closely related to GFR [7]. It is for this reason
that we consider mesangial volume fraction to be the most
important structural endpoint in the current study.
We need to address why only the D-50 rats developed
fractional mesangial expansion in the current study while, in
our previous studies, we have been able to document similar
lesions developiilg in Lewis rats on a 20% protein intake after
apptoximately seven months of diabetes [8—10]. The failure of
D-20 rats studied here to develop these lesions may have been
because the diabetic state of these rats was milder and the
duration somewhat shorter than that of diabetic rats in our
earlier studies [8—12]. Duration was also longer in the studies of
Orloff et al [291. These investigators also documented increased
mesangial volume fraction in long-term severely diabetic rats
untreated with insulin [29]. In fact, one could argue that diabetic
rats are highly resistant to developing increased mesangial
volume fraction unless the hyperglycemia is very severe. For
example, BB Wistar rats require insulin to avoid death from
ketoacidosis, and thus, are of necessity maintained with less
severe hyperglycemia than can be tolerated long term by insulin
untreated rats from other strains. These BB Wistar rats do not
develop mesangial expansion although they have glomerular
hyperfiltration [30]. Similarly, treatment of hyperglycemia with
insulin in other rat strains partially or completely prevents
diabetic renal structural abnormalities, depending on the preci-
sion of glycemic control [31—34].
The animals in the current study did not develop focal
segmental or global glomerulosclerosis. However, increased
focal segmental glomerulosclerosis (FSGS) occurs in certain
10
• E 1.0
x
p
>.
0.1
.
0
00
...0
0
0
8
0
'8I
00
00
..00
•000
.0
50%
Protein
diet
20%
Protein
diet
Mauer et at: Dieta,y protein intake in diabetic rats 55
diabetic rat models. Zatz et al have shown that Munich-Wistar
rats, their diabetic state modulated by daily insulin treatment,
develop FSGS in association with increased glomerular capil-
lary pressures and flows [16]. Further, these investigators have
demonstrated that steps taken to normalize these hemodynamic
perturbations prevent the FSGS lesions from developing [16,
35]. However, animals in the insulin ameliorated model of
diabetes studied by these investigators do Pot develop an
increase in volume fraction of the mesangium [17]. Further,
FSGS is neither a common nor an important lesion in diabetes
in humans [4, 5, 361. In fact, Heptinstall suggests that the
Kimmelsteil-Wilson nodular lesion of diabetic nephropathy in
man should not be confused with that of FSGS. Although global
sclerosis of glomeruli is increased in patients with long-standing
type I diabetes [4, 5, 36], it is increased mesangial volume
fraction rather than percent sclerotic glomeruli which is more
closely related to GFR and to the onset of overt diabetic
nephropathy [4, 5, 7]. One possible interpretation of these data
could be as follows: Severe untreated diabetes in rats is not
associated with hyperfiltration [15, 37] but is necessary for the
development of increased volume fraction of the mesangium [8,
91. The less severe diabetes associated with the treatment of
diabetic rats with insulin is accompanied by glomerular hyper-
filtration but is not associated with fractional mesangial expan-
sion. Thus, severely diabetic rats develop increased mesangial
volume fraction without glomerular hyperfiltration, while less
severely diabetic insulin-treated rats develop hyperfiltration
without this important glomerular lesion. Unlike man, the
coexistence of hyperfiltration and diffuse fractional mesangial
expansion has not been documented in the rat. From this it may
Table S. Renal function studies in diabetic and control animals at 2 months-model parameters
Blood Body Kidney
glucose weight weight
mgldl g KW/BW
Mean
arterial BP
mm Hg
Hct
%
20% 129 298 1.02 0.0034 129 48
Control SD 10 32 0.19 0.00039
N 5 17 17 17
10.2
17
0.01
17
50% 105 309 1.3 0.0042 127 51
Control SD 17 25 0.15 0.0003
N 5 15 15 15
14.0
15
0.02
15
20% 523 180 1.3 0.0074 113 49
Diabetic SD 65 21 0.22 0.0011
N 12 17 17 17
12.3
17
0.03
17
50% 451 210 1.65 0.0079 119 51
Diabetic SD 27 29 0.22 0.0009
N 10 14 14 14
8.8
14
0.02
14
ANOVA P value
Diabetes 0.001 0.001 0.001 0.001 0.001 NS
Diet 0.02 0.001 0.001 0.001 NS 0.001
Diabetes x diet 0.02 NS NS NS NS NS
Abbreviations are: KW/BW, ratio of kidney weight to body weight; BP, blood pressure; Hct, hematocrit.
Table 6. Renal function studies at 2 months
GFR RPF RA RE COP PGC PT F
mi/mm FF dyne-sec cm5 x mm Hg
20% 1.8 9.9 0.19 34.8 17.2 15.5 51.7 11.6 40.0
Control SD
N
0.30
17
2.8
15
0.03
15
10.0
13
11.1
13
1.0
17
3.9
14
1.7
IS
3.6
14
50% 2.31 11.6 0.21 24.9 40.8 15.6 55.9 12.2 43.5
Control SD
N
0.36
15
2.7
12
0.04
12
6.8
8
6.0
8
1.1
15
5.4
14
2.0
14
5.3
14
20% 1.67 6.4 0.27 42.3 23.4 14.7 48.2 11.2 37.1
Diabetic SD
N
0.30
17
2.0
13
0.05
13
10.3
10
13.9
10
1.6
16
4.5
15
1.4
16
4.5
15
50% 2.01 8.36 0.25 32.6 38.0 14.7 54.0 11.2 42.0
Diabetic SD
N
0.27
14
1.9
13
0.05
13
8.2
12
18.7
12
1.1
14
4.1
14
1.8
14
3.1
14
ANOVA P value
Diabetes 0.008 0.001 0.001 0.025 0.005 0.01 0.008 NS 0.025
Diet 0.007 0.007 NS 0.001 NS NS 0.001 NS 0.001
Diabetes x diet 0.097 0.097 NS NS NS NS NS NS NS
Abbreviations are: GFR, glomerular filtration rate; RPF, renal plasma flow; FF, filtration fraction; RA, afferent arteriolar resistance; RE, efferent
arteriolar resistance; COP, colloid osmotic pressure; PGC, glomerular capillary pressure; PT, tubular pressure; 1P, transcapillary hydraulic
pressure difference.
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be argued that the diabetic rat is a less than ideal model in which
to study the impact of glomerular hemodynamics on the critical
lesions of diabetic glomerulopathy.
Further, given glomerular hemodynamic stress, certain
strains of rats may be more susceptible to developing FSGS
than some other rat strains. For example, Grond et al have
shown that the Wistar rat strain have 20% of glomeruli involved
with FSGS within one year of uninephrectomy while unineph-
rectomy in the PVG/c strain of rat results in a 0% incidence of
this lesion after one year [38]. We found virtually no lesions of
FSGS in diabetic and nondiabetic intact and uninephrectomized
Lewis rats followed for almost one year [9, 11] and we have
confirmed this on a recent blind rereading of the kidney
histology from those studies (unpublished data). Hostetter,
Troy and Brenner [15] and Zatz et al [16, 35] found increased
PGC in insulin-treated diabetic Munich-Wistar rats, and Bank
et al, using the stopped flow technique, found a similar increase
in PGC in insulin-treated diabetic WKY rats [391. On the other
hand, Michels, Davidman and Keane [37] and Jensen et al [401
were both unable to find increased PGC measured by the
stopped flow technique in insulin-treated Sprague-Dawley and
Wistar rats, respectively. Thus, not all strains of insulin-treated
diabetic rats with glomerular hyperfiltration have increased
PGC. It may be that the tendency for diabetic rats with
hyperfiltration to develop FSGS is dependent upon glomerular
capillary hypertension. If so, this might explain some of the
strain differences which have been observed. Nonetheless, it is
entirely unclear which, if any, of the rat strains studied to date
can be considered representative of the glomerular hemody-
namic pertubations which accompany increased GFR in pa-
tients with type I diabetes.
Interestingly, the hemodynamic effects of mild to moderate
diabetes [15] and uninephrectomy in Munich-Wistar rats [13]
are remarkably similar yet as we have shown, uninephrectomy
per se causes no increase in mesangial volume fraction in
nondiabetic rats [9, 10]. The increase in total mesangium per
glomerulus which occurs in these diabetic uninephrectomized
rats [10] and in the insulin-treated Munich-Wistar rat [17] is
entirely due to increased glomerular size with proportional
mesangial enlargement. Moreover, in an earlier report, based
on increased total mesangium per glomerulus [91, we suggested
that uninephrectomy accelerated mesangial expansion in se-
verely diabetic (insulin untreated) Lewis rats. Recalculation of
these data as mesangial volume fraction showed no effect of
uninephrectomy [10] on this structural parameter. Thus the
increase in mesangial volume in uninephrectomized diabetic
rats was proportional to the increase in glomerular volume
which resulted from uninephrectomy. There is, in fact, no
direct evidence that increasing RBF or PGC, per se, increases
the rate at which mesangial volume fraction increases in dia-
betic rats.
It might be argued that the diabetic animals in the current
study, especially those on the high protein diet, had glomerular
hyperperfusion and hyperfiltration if these parameters were
calculated based upon body weight. However, such calculated
hyperfiltration provides little basis for the understanding of the
pathogenesis of the important lesions of diabetic nephropathy.
Since glomerular morphogenesis is entirely complete by the age
at which the rats in the current study were made diabetic [41],
there is no reason to believe that glomerular number varied
between any of the groups studied. Also, the size of the
glomeruli at two months was similar in all groups of rats
studied. The hypothesis that it is primarily hemodynamic forces
which mediates glomerular injury in diabetic nephropathy [15,
16, 35] was not developed upon calculated hyperfiltration based
on body weight. Instead this hypothesis argues that it is the
exposure of individual glomeruli to increased hemodynamic
stresses induced by the diabetic state, specifically increased
glomerular capillary pressures and flows, which result in struc-
tural alterations and in functional disturbances such as protein-
uria and which drive the glomerulus towards destruction. There
is no reason to believe that because the glomeruli exists in a
kidney within a smaller as compared to a larger rat that they
somehow are under increased or decreased risk of injury
mediated by hemodynamic forces. Similar logic would argue
against the factoring of any of the glomerular hemodynamic
parameters for kidney size which, in fact, was increased con-
sequent to diabetes in the present studies.
The studies of PGC performed in insulin-treated diabetic
Munich-Wistar rats clearly indicate that our techniques of
indirect PGC measurements were sufficiently sensitive to have
detected an increase in PGC in the diabetic Lewis rats should
this have been present. From this, it can be argued that neither
hyperfiltration nor increased renal blood flow nor glomerular
capillary hypertension are necessary preconditions for the
glomerular mesangial changes seen in the D-50-6 rats but not in
the other groups. It is possible that the slight relative increase in
GFR, RBF and PGC at two months in the diabetic rats on the
high as compared to the normal protein diets reflected hemo-
dynamic processes sufficient to accelerate diabetic mesangial
lesions in the former group. To accept this hypothesis one
would have to imagine that the diabetic glomerulus is vulnera-
ble even to normal glomerular capillary pressures and flows and
that reductions in these forces to subnormal levels may reduce
the rate of glomerular injury. This is a tenable hypothesis and
the design of the current study does not address this question.
In fact, studies suggesting protection from diabetic changes in
the "clipped" kidneys in two-kidney Goldblatt hypertensive
rats [12] support this notion. Nonetheless, failure to detect
mesangial volume fraction expansion in the nondiabetic animals
on the high compared to the normal protein diet in the present
study, and in the nondiabetic uninephrectomized compared to
intact animals in our previous studies [10], argues strongly that
hemodynamic factors per se are insufficient to produce these
lesions. Thus, the corollary of the hypothesis that the diabetic
glomeruli may be vulnerable to normal intraglomerular hemo-
dynamic forces is the acceptance of a critical and specific role of
the diabetic state in the pathogenesis of diabetic nephropathy.
Finally, maneuvers that reduce glomerular blood flow might
also reduce the delivery rate of potentially noxious molecules
such as glucose [42—45] to the glomerulus, and it may be this
alone or in combination with hemodynamic forces which medi-
ate the glomerulopathy of diabetes.
The mechanism by which the high protein diet influenced the
mesangium of the animals in these studies is not known. Since
diabetic (and control) animals on 50% protein intake had
somewhat lower glucose levels than animals on the 20% protein
diet, hyperglycemia per se could not explain these findings.
However, it should be noted that the diabetic animals on the
normal diet did not have increased mesangial volume fraction,
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presumably because the diabetes was not of adequate severity
and duration [8, 10, 301. Nonetheless, as argued above, since
fractional mesangial expansion occurred only in the diabetic
rats on the high protein diet, it is reasonable to conclude that the
diabetic state is a necessary prerequisite for these structural
changes to occur. Recently it has been learned that glomeruli
isolated from diabetic rats on a high protein diet have a further
increase in the activity of a biochemical pathway important in
glomerular matrix production above that induced by the dia-
betic state alone (Cortes, P., personal communication). Further
studies in this direction should prove useful.
Another hypothesis which has been advanced to explain
mesangial expansion in diabetes supposes a disturbance in the
mesangial function of uptake and processing of macromolecules
[46]. This hypothesis has recently been advanced in an attempt
to explain accelerated mesangial expansion in uninephrecto-
mized insulin-treated diabetic Sprague-Dawley rats that have
hyperfiltration without glomerular capillary hypertension [471.
It is true that mesangial immunoglobulin and complement
localization are increased in diabetic compared to normal rats
[48] and mice [49], and that uninephrectomy results in dramatic
further increases these changes [11, 49]. However, we have
previously shown that the mesangial uptake and processing of
colloidal carbon in diabetic rats is normal except for those areas
of the mesangium already thickened as a consequence of long
standing diabetes [501. Thus, disturbance in the macromolecu-
lar processing function of the mesangium may more likely be a
consequence rather than a cause of mesangial expansion.
Nonetheless, a cycle of diabetic mesangial expansion, in-
creased macromolecular deposition and further injury with
matrix production and accumulation and continued expansion
could be involved. It is not known how the dietary manipula-
tions studied here might influence these mesangial processes.
Urinary albumin excretion (UAE) in these studies was influ-
enced both by diabetes, diet and also by time. We have
previously shown that UAE increases gradually in normal rats
[21]. Diabetic animals on the normal protein diet had increased
UAE and even greater increases were documented in diabetic
animals on the high protein diet, especially at six months.
Proteinuria in rats has been associated with increased mesangial
macromolecular uptake [51, 52]. Therefore, it is possible that
mesangial uptake of circulating phlogistic macromolecules is
enhanced in proteinuric diabetic rats and contributes to a
circular pattern of injury, proteinuria and further injury [46].
However, it should be pointed out that increased mesangial
deposition of immune reactants does not generally occur in
diabetic nephropathy in man [53, 541, this perhaps, reducing the
potential relevance of the "mesangial overload" hypothesis to
human diabetic renal disease.
The basis for increased urinary albumin excretion (UAE) in
diabetic nephropathy has not been clearly established. The
mechanisms of increased UAE in diabetic rats with hyperfiltra-
tion with or without glomerular capillary hypertension are
probably not the same as in animals without these physiologic
changes. Albuminuria can be diminished in the former by
maneuvers which tend to normalize the hemodynamic abnor-
malities [16, 35] while in the latter, as demonstrated here, the
increased UAE develops and progresses in the absence of these
hemodynamic disturbances. Thus, it is reasonable to conclude
that albuminuria occurring in diabetic rats can result from
multiple and separate influences. The albuminuria occurring in
insulin-treated moderately diabetic rats with hyperfiltration [15,
16, 351 may be analogous to that which occurs in rats with
glomerular hyperfiltration from other causes [21]. However, it
should be understood that the abnormalities in permselectivity
documented here are orders of magnitude less than the marked
breakdown in the glomerular size selective barrier which occurs
in overt diabetic nephropathy in humans [55, 56]. As empha-
sized above, this overt proteinuria in humans is virtually always
associated with marked fractional mesangial expansion [4] far
beyond that which developed in the diabetic rats studied here.
The mechanism whereby high protein intake increases UAE in
diabetic rats is unexplained by the present study, but could
relate to intrinsic defect(s) in the capillary wall barrier mecha-
nisms, perhaps coupled with the normal glomerular capillary
hemodynamic forces seen in diabetic animals on the high
protein diet as compared to the reduced hemodynamic forces in
diabetic animals on the normal protein diet.
Group comparisons showed that food intake was greater in
diabetic than control animals. Also, urinary urea nitrogen
excretion was higher in diabetic than in their respective control
groups. Thus, diabetic rats on a "normal" diet had roughly a
50% higher protein intake, urea nitrogen excretion and, presum-
ably, absorbed 50% more protein than did nondiabetic rats. The
influence of protein intake on renal structure and function in
diabetic rats cannot be interpreted without considering this
important but heretofore neglected variable. For example, the
development or acceleration of lesions of focal segmental
glomerulosclerosis of aging can be induced in certain strains of
nondiabetic rats [57-60] with alterations in protein intake of a
magnitude similar to those documented here in diabetic rats on
a "normal" protein diet. This relative hyperphagia in diabetic
rats which probably reflects, at least in part, increased glucose
losses in urine is reminiscent of the Zucker rat 161, 62] and
models of hyperphagia induced by experimental hypothalamic
lesions in rats [59]. It is possible that, at least in part, the
hyperfiltration documented in the insulin-treated diabetic rat
model could be a result of increased protein intake. Supporting
this are the recent observations of Kupin et al [63] showing that
GFR and RBF are both correlated with protein intake in both
type I diabetic patients and normal controls, and that these
renal functional parameters are no different in the diabetic
compared to the control patients when corrected for dietary
protein intake as measured by urea nitrogen excretion.
In summary, diabetic rats given normal or increased protein
intake in their diets have normal or reduced levels of glomerular
filtration rate, renal blood flow and glomerular capillary pres-
sure compared to control rats on normal and increased dietary
protein. While diabetic rats on 20% and 50% protein diet
developed equivalent GBM thickening, only the high protein
diabetic rats in these studies developed diffuse mesangial ex-
pansion expressed as an increase in the volume fraction of this
structural parameter by electron microscopic morphometric
analysis after six months of diabetes. Thus, this study shows an
acceleration of the most important glomerular lesion of diabetes
by increased protein intake through mechanisms which do not
depend upon abnormalities in intraglomerular hemodynamics
as measured here. The pathogenesis of this dietary influence
was not elucidated by these studies. The possibility exists that
normal glomerular hemodynamic forces could contribute to
58 Mauer el a!: Dietary protein intake in diabetic rats
mesangial expansion in these diabetic rats or that factors other
than glomerular hemodynamics are of primary importance in
the genesis of these lesions. Clearer understanding of factors
governing mesangial matrix production and turnover and, per-
haps, improved techniques permitting renal physiologic studies
in less manipulated rats may be required to answer the ques-
tions raised here.
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